Primary HIV-1 infection in African children infected through breastfeeding

AIDS

Volumn 16, Issue 17, 2002, Pages 2303-2309

  Rouet, François ^a,b   Elenga, Narcisse ^b   Msellati, Philippe ^b,c   Montcho, Crépin ^a,b   Viho, Ida ^b   Sakarovitch, Charlotte ^d   Danel, Christine ^b   Rouzioux, Christine ^e   Leroy, Valériane ^d   Dabis, François ^d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^b Programme PAC CI   (Côte d’Ivoire)

^c IRD/LPE   (France)

^d INSERM   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Africa; Breastfeeding; Children; HIV 1 RNA viral load; Primary HIV 1 infection

Indexed keywords

DNA; RENIN; RNA;

AFRICA; ARTICLE; BREAST FEEDING; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DERMATITIS; DNA DETERMINATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; NEWBORN; NEWBORN PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; VIRAL CONTAMINATION; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

ACUTE DISEASE; BREAST FEEDING; CASE-CONTROL STUDIES; COTE D'IVOIRE; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 0037159918     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200211220-00010     Document Type: Article

References (23)

1. Daar ES, Little S, Pitt J, Santangelo J, Ho P, Harawa N, et al. Diagnosis of primary HIV-1 infection. Ann Intern Med 2001, 134:25-29.
2. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998, 339:33-39.
3. Lefrere JJ, Roudot-Thoraval F, Mariotti M, Thauvin M, Lerable J, Salpetrier J, et al. The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis 1998, 177:1541-1548.
4. Dorrucci M, Rezza G, Vlahov D, Pezzotti P, Sinicco A, Nicolosi A, et al. Clinical characteristics and pronostic value of acute retroviral syndrome among injecting drug users. AIDS 1995, 9:597-604.
5. Rouzioux C, Costagliola D, Burgard M, Blanche S., Mayaux MJ, Griscelli C, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995, 142:1330-1337.
6. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 2000, 283:1167-1174.
7. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'lvoire and Burkina Faso: A double-blind placebo-controlled multicentre trial. Lancet 1999, 353:786-792.
8. Rees H. Clinical trials and regulatory issues in developing countries. AIDS 2001, 15:S66-S68.
9. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002, 359:2097-2104.
10. Msellati P, Meda N, Leroy V, Likikovët R, Van de Perre P, Cartoux M, et al. Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west-Africa: ANRS 049h phase II randomised, double blinded placebo controlled trial. Sex Transm Infect 1999, 75:420-425.
11. Meda N, Leroy V, Viho I, Msellati P, Yaro S, Mandelbrot L, et al. Field acceptability and effectiveness of a routine utilisation of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. AIDS 2002 (in press).
12. Centers for Disease Control and Prevention. 1994 Revised classification systems for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43(No. RR-12):1-19.
13. Rouet F, Montcho C, Rouzioux C, Leroy V, Msellati P, Kottan JB, et al. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS 2001, 15:1849-1856.
14. Vanhems P, Allard R, Cooper DA, Perrin L, Vizzard J, Hirschel B. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: Is the diagnosis too restrictive? Clin Infect Dis 1997, 24:965-970.
15. Colebunders R, Ryder R, Francis H, Nekwei W, Bahwe Y, Lebughe I, et al. Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J Infect Dis 1991, 164:450-456.
16. Lavreys L, Thompson ML, Martin HL. Primary human immunodeficiency virus type 1 infection: Clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis 2000, 30:486-490.
17. Morgan D, Mahe C, Whitworth J. Absence of a recognizable seroconversion illness in Africans infected with HIV-1. AIDS 2001, 15:1575-1576.
18. Biggar RJ, Broadhead R, Janes M, Kumwenda N, Taha TET, Cassol S. Viral levels in newborn African infants undergoing primary HIV-1 infection. AIDS 2001, 15:1311-1313.
19. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002, 16:1119-1129.
20. Toni TD, Masquelier B, Bonard D, Faure M, Huët C, Caumont A, et al. Primary HIV-1 drug resistance in Ahidjan (Cote d'lvoire): A genotypic and phenotypic study. AIDS 2002, 16:488-491.
21. Abrams EJ, Weedon J, Steketee RW, Lambert G, Bamji M, Brown T, et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. J Infect Dis 1998, 178:101-108.
22. Biggar RJ, Janes M, Pilon R, Miotti P, Taha TET, Broadhead R, et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J Infect Dis 1999, 180:1838-1843.
23. Berrey MM, Schacker T, Collier AC, Shea T, Brodie SJ, Mayers D, et al. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis 2001, 183:1466-1475.